Interpharma Public Company Limited is a Thailand-based company that develops, researches and distributes healthcare products and beauty initiatives for human beings, and healthcare products for animals. The Company provides wellness and anti-aging products, aesthetic innovation products, companion animal health products and livestock products. Its products include PREBO, YUUU toothpaste, multivitamin, Probac 7, Probac 10, Beta Glucan Plus, Pure Krill Oil, Astacurmin, YUUU cleansing mousse, Perfectha Complement, Perfectha Derm, Perfectha Deep, Perfectha Subskin and Uderma.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
24/08/26	THB 5.050	+1.41%	61,800
24/08/26	THB 4.980	-2.35%	266,800
21/08/26	THB 5.100	-0.97%	54,300
20/08/26	THB 5.150	+0.98%	162,200
19/08/26	THB 5.100	-5.56%	930,000

End-of-day quote Thailand S.E.

More quotes

Annual profits - Rate of surprise

Company calendar

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Thailand S.E. 25/08/2026			5-day change	1st Jan Change
5.050 ^THB	+1.41%		-7.34%	+9.78%

08-14	Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-11	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	3.06B 93.38M 80.02M 74.98M 68.49M 129M 8.9B 131M 884M 344M 4.49B 351M 343M 14.87B	P/E 2024	52.3x	P/E 2025	22.8x
Enterprise Value	3.18B 97.03M 83.14M 77.91M 71.16M 134M 9.25B 136M 919M 358M 4.67B 364M 356M 15.46B	EV / Sales 2024	1.13x	EV / Sales 2025	1.31x
Free-Float	-	Yield 2024 *	-	Yield 2025	1.59%

08-14	Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-11	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-02	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-01	Inter Pharma Public Company Limited announces Annual dividend, payable on May 25, 2026	CI
11-11	Inter Pharma Public Company Limited (SET:IP) agreed to acquire an additional 49% stake in Interpharma- ZEAvita Company Limited from Thai Union Ingredients.	CI
11-11	Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
13/05/25	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
16/04/25	Zhaoke Ophthalmology, Interpharma Strike Thailand Drug Distribution Deal	MT
16/04/25	Zhaoke Ophthalmology Limited Enters into Three Distribution and Supply Agreements with Interpharma Public Company Limited	CI
01/04/25	Inter Pharma Public Company Limited Signs Exclusive Distribution Agreement with Zhaoke Ophthalmology Company Limited for Comprehensive Eye Care Innovation	CI
25/02/25	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25/02/25	Inter Pharma Public Company Limited Proposes to Omit Dividend Payment for the Year Ended December 31, 2024	CI

17/08/22	Inter Pharma : New shares of IP to be traded on August 18, 2022	PU
10/08/22	Inter Pharma Public : Notification on Change of Directors and Authorization of Directors	PU
10/08/22	Inter Pharma Public : Report on the results of sale of common shares offered to private placement (F53-5)	PU
10/08/22	Inter Pharma Public : Right Adjustment of IP-W1 (Edited)	PU
10/08/22	Inter Pharma Public : Right Adjustment of IP-W1	PU

Inter Pharma Share Price Thailand S.E.

Stocks

IP-R

TH9474010R16

Pharmaceuticals

Valuation: Inter Pharma

Chart: Inter Pharma

Latest news : Inter Pharma

Press Releases: Inter Pharma

Quotes and Performance

Course Extremes

Managers and Directors: Inter Pharma

Other Pharmaceuticals

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

1 day	+1.41%
1 week	-7.34%
Current month	-4.72%
1 month	-6.48%
3 months	+21.39%
6 months	+23.77%
Current year	+9.78%

1 week	4.96	5.4
1 month	4.96	5.65
Current year	3.68	5.65
1 year	3.14	5.65
3 years	2.02	7.3
5 years	2.02	14.46
10 years	1.62	15.14

Manager	Title	Age	Since
Trinnawat Thanitnithiphan CEO	Chief Executive Officer	56	31/01/2014
Chatkaew Krudkosol DFI	Director of Finance/CFO	56	22/06/2023
Chompunuch Meevang CMP	Compliance Officer	54	-

Director	Title	Age	Since
Napaporn Dechakarat BRD	Director/Board Member	51	13/06/2017
Sansanee Chaiyaroj BRD	Director/Board Member	64	31/07/2020
Trinnawat Thanitnithiphan BRD	Director/Board Member	56	31/01/2014

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INTER PHARMA	+1.41%	-7.34%	-	-	92.23M
ELI LILLY AND COMPANY	+0.07%	+1.98%	+79.77%	+125.77%	1,111B
JOHNSON & JOHNSON	+0.36%	+0.72%	+53.05%	+64.24%	658B
ABBVIE INC.	+0.59%	+2.78%	+28.22%	+81.42%	467B
ROCHE HOLDING AG	+0.92%	+3.57%	+43.82%	+44.21%	369B
NOVARTIS AG	+1.25%	+2.21%	+26.77%	+43.05%	301B
ASTRAZENECA PLC	+3.02%	+5.68%	+5.09%	+17.04%	256B
AMGEN INC.	+0.12%	+4.45%	+53.99%	+73.26%	240B
NOVO NORDISK A/S	+2.86%	+3.86%	-16.20%	-51.83%	207B
GILEAD SCIENCES, INC.	+0.74%	+2.99%	+29.41%	+92.20%	182B
Average	+1.15%	+4.49%	+33.77%	+54.37%	421.22B
Weighted average by Cap.	+0.77%	+4.68%	+46.75%	+73.17%

	2024	2025
Net sales	1.91B 58.41M 50.05M 46.9M 42.84M 80.84M 5.57B 81.64M 553M 215M 2.81B 219M 215M 9.3B	2.21B 67.63M 57.96M 54.31M 49.6M 93.62M 6.45B 94.54M 641M 249M 3.25B 254M 248M 10.77B
Net income	37.28M 1.14M 976K 914K 835K 1.58M 109M 1.59M 10.79M 4.2M 54.77M 4.28M 4.18M 181M	122M 3.74M 3.2M 3M 2.74M 5.17M 356M 5.23M 35.41M 13.78M 180M 14.04M 13.73M 595M
Net Debt	209M 6.38M 5.47M 5.12M 4.68M 8.83M 608M 8.92M 60.44M 23.53M 307M 23.96M 23.44M 1.02B	119M 3.64M 3.12M 2.93M 2.67M 5.04M 347M 5.09M 34.51M 13.44M 175M 13.68M 13.38M 580M